Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 8-K Event New debt or obligation
  2. 4 Grant or award Director acquired 40,000 shares (grant or award)
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-K Report Annual Report
  5. 8-K Event Results of operations
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4/A Derivatives Options or other derivatives
  9. 4/A Derivatives Options or other derivatives
  10. 4/A Derivatives Options or other derivatives
  11. 4/A Derivatives Options or other derivatives
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 8-K Event Executive or director change
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Material agreement · Other events
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 16 of 47 · 923 filings